by palligoelme@gmail.com | Sep 16, 2025 | Clinical Trials
Conditions: Glaucoma Interventions: Drug: Rocklatan eye drops will be instilled nightly in one eye diagnosed with glaucoma for up to 12 months.; Device: Two optical coherence tomography (OCT) devices will be used to assess blood flow changes. Sponsors: Oregon Health...
by palligoelme@gmail.com | Sep 16, 2025 | Clinical Trials
Conditions: Advanced Malignant Solid Neoplasm; Malignant Brain Neoplasm; Recurrent Advanced Malignant Solid Neoplasm Interventions: Behavioral: Advance Care Planning; Other: Educational Intervention; Other: Electronic Health Record Review; Other: Survey...
by palligoelme@gmail.com | Sep 16, 2025 | Clinical Trials
Conditions: Desmoid Tumor; Aggressive Fibromatosis Interventions: Drug: Nirogacestat Sponsors: SpringWorks Therapeutics, Inc. Recruiting Conditions: Desmoid Tumor; Aggressive Fibromatosis Interventions: Drug: Nirogacestat Sponsors: SpringWorks Therapeutics, Inc....
by palligoelme@gmail.com | Sep 16, 2025 | Clinical Trials
Conditions: Non-Small Cell Lung Cancer Interventions: Drug: IN10018 in combination with D-1553; Drug: anti-PD-1 monoclonal antibody in combination with platinum and pemetrexed Sponsors: InxMed (Shanghai) Co., Ltd. Not yet recruiting Conditions: Non-Small Cell Lung...
by palligoelme@gmail.com | Sep 15, 2025 | Clinical Trials
Conditions: Cirrhosis; Decompensation; Transjugular Intrahepatic Portosystemic Shunt (TIPS); Survival Analysis Sponsors: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology; Zhongnan Hospital; Yichang Central People’s...
